NCT01731951 2021-09-21Imetelstat Sodium in Treating Participants With Primary or Secondary MyelofibrosisGeron CorporationPhase 2 Completed80 enrolled 31 charts
NCT01836549 2018-07-20Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsPediatric Brain Tumor ConsortiumPhase 2 Terminated43 enrolled 14 charts